Search

everythinglearnresearchcommunity

for

Search:↓

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Alopecia areata patients should have eye check-ups due to increased risk of eye problems.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Statins may help treat alopecia areata by reducing harmful immune interactions.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Stress hormones and autoimmune reactions can cause hair loss.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Sorafenib may cause hair loss in a way similar to alopecia areata.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Linalool in fragrances may harm hair follicles and contribute to hair loss.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.